All articles tagged: HIV/AIDS

The cosmetic procedures took place at a spa performing microneedling facials using unsterile injection practices.

New restrictions have been imposed by the European Medicines Agency on the coadministration of the anti-HIV drug atazanavir with a variety of other agents.

The acronym is no longer useful and may be harmful, according to a group of specialists who are debating the concept with other experts.

The single-pill combination of bictegravir-lenacapavir shows good virologic suppression and tolerability in a 2-year clinical trial; about 8% of people with HIV are still on complex regimens.

A nurse-led multicomponent strategy significantly reduced systolic blood pressure and non-HDL cholesterol in HIV patients and should be included in HIV primary care programs.

The last attempt in a generation of HIV vaccine development ended in disappointment, but investigators are starting over because they believe the human body can make antibodies for HIV.

Vaccinations were stopped after it became clear they would not be effective. "We cannot and will not lose hope that the world will have an effective HIV vaccine," the International AIDS director said.

A trial of an experimental HIV vaccine stopped early after preliminary data suggested it would not be effective in preventing infection, according to the trial's chief investigator.

Europe's advances in HIV prevention strategies, including PrEP and long-acting retrovirals, bring hope amidst persistent access challenges and disparities.

Singer Elton John addressed British lawmakers on Wednesday as the government announced plans to expand an HIV testing programme as part of its aim to end new transmissions of the virus in England by 2030.

What would happen if the medical community trained women in at-risk communities to help each other take better care of themselves and get rid of the stigma of conversations about sexual health?

HIV can take an emotional toll on patients whether it was diagnosed days ago or decades before, but the issues patients must contend with have changed over time.

With neurocognitive disorders affecting about 40% of people with HIV, investigators launched the Think Fast Study evaluating a new training approach in a 2-year trial.

The monthly to bimonthly injectable regimens help overcome challenges that some patients face with daily pills.

Preexposure prophylaxis is highly effective in preventing HIV and yet uptake can be low among women, report researchers who say mobile technologies can help.

The failure of Congress to reauthorize the main program aimed at reducing the spread of AIDS sends a message that Washington is 'backing down' from its leadership on the issue, a spokesperson said on Monday.